IN2013MU01920A - - Google Patents

Download PDF

Info

Publication number
IN2013MU01920A
IN2013MU01920A IN1920MU2013A IN2013MU01920A IN 2013MU01920 A IN2013MU01920 A IN 2013MU01920A IN 1920MU2013 A IN1920MU2013 A IN 1920MU2013A IN 2013MU01920 A IN2013MU01920 A IN 2013MU01920A
Authority
IN
India
Prior art keywords
disclosed
conditions
thiazolyl
obesity
cancers
Prior art date
Application number
Inventor
Kunju Vasu Kamala
Suresh Thacker Pavitra
Anilkumar Sharma Jayesh
Abhiramasundari A
Original Assignee
Kamala K Vasu Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kamala K Vasu Dr filed Critical Kamala K Vasu Dr
Priority to IN1920MU2013 priority Critical patent/IN2013MU01920A/en
Publication of IN2013MU01920A publication Critical patent/IN2013MU01920A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Herein the new use of thiazolyl analogues against diabetes, obesity are disclosed having utility in treating inflammatory conditions, immunoinflammatory conditions, autoimmune diseases, and cancers. Methods for the synthesis of these compounds are also disclosed.
IN1920MU2013 2013-05-31 2013-05-31 IN2013MU01920A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN1920MU2013 IN2013MU01920A (en) 2013-05-31 2013-05-31

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1920MU2013 IN2013MU01920A (en) 2013-05-31 2013-05-31

Publications (1)

Publication Number Publication Date
IN2013MU01920A true IN2013MU01920A (en) 2015-09-25

Family

ID=54394961

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1920MU2013 IN2013MU01920A (en) 2013-05-31 2013-05-31

Country Status (1)

Country Link
IN (1) IN2013MU01920A (en)

Similar Documents

Publication Publication Date Title
HK1222552A1 (en) Sobetirome in the treatment of myelination diseases
MX366804B (en) R-spondin translocations and methods using the same.
HRP20180631T1 (en) Mini-gastrin analogue, in particular for use in cck2 receptor positive tumour diagnosis and/or treatment
MX2016003129A (en) Combination therapy of antibodies against human csf-1r and antibodies against human pd-l1.
MX2015015249A (en) Therapeutic peptides.
PH12015501071A1 (en) Combination therapy of anti-her3 antibodies
GEP201706612B (en) Methods for the treatment of breast cancer
EP2996721A4 (en) Methods and compositions for prognosis, diagnosis and treatment of adam8-expressing cancer
HK1219232A1 (en) Arginine deiminase with reduced cross-reactivity toward adi - peg 20 antibodies for cancer treatment adi-peg 20
MX365403B (en) Peptides and methods of using same.
PH12015500169A1 (en) Prediction of treatment response to jak/stat inhibitor
WO2014197835A3 (en) Methods and compositions for the treatment of cancer
GB2516814B (en) Use of phytocannabinoids for increasing radiosensitivity in the treatment of cancer
IN2015DN00515A (en)
HK1214752A1 (en) Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens
EP3015864A4 (en) Biomarkers for the diagnosis and the response to treatment of pancreatic cancer
MX2015010023A (en) Anti-cd83 antibodies and use thereof.
EP2983693A4 (en) Sept4/ARTS AS A TUMOR SUPPRESSOR IN THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF HEPATIC DISORDERS
PH12016501183A1 (en) Novel compound for treatment of severe hypoglycemia
PT2984108T (en) Anti-s100a7 antibodies for the treatment and diagnosis of cancer
PH12016501182A1 (en) Novel compound for treatment of severe hypoglycemia
PH12016501184A1 (en) Novel compound for treatment of severe hypoglycemia
IS2934B (en) Molybdenum compounds for use in the treatment of Cyanide poisoning
PL2943215T3 (en) Lactoferricin derived peptides for use in the treatment of cancer
IN2013MU01920A (en)